Endothelium removal induces iNOS in rat aorta in organ culture, leading to tissue damage

American Journal of Physiology - Endocrinology and Metabolism

Volumn 276, Issue 1 39-1, 1999, Pages

  Binko, J ^a   Meachem, S ^a   Majewski, H ^a  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Apoptosis; Injury; Nitric oxide synthase; Smooth muscle

Indexed keywords

NITRIC OXIDE SYNTHASE;

ANIMAL TISSUE; AORTA MEDIA; APOPTOSIS; ARTICLE; BLOOD VESSEL TONE; DNA DAMAGE; ENDOTHELIUM CELL; IMMUNOREACTIVITY; INTRINSIC SYMPATHOMIMETIC ACTIVITY; NONHUMAN; ORGAN CULTURE; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE; SMOOTH MUSCLE FIBER; THROMBOCYTE AGGREGATION; TISSUE INJURY; VASCULAR ENDOTHELIUM;

EID: 0032923534     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1999.276.1.e125     Document Type: Article

References (53)

1. Barker, J. E., J. P. Bolanos, J. M. Land, J. B. Clark, and S. J. Heales. Glutathione protects astrocytes from peroxynitrite-mediated mitochondrial damage: implications for neuronal/ astrocyte trafficking and neurodegeneration. Dev. Neurosci. 18: 391-396, 1996.
2. Bauters, C., and J. M. Isner. The biology of restenosis. Prog. Cardiovasc. Dis. 40: 107-116, 1997.
3. Beckman, J. S., and W. H. Koppenol. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am. J. Physiol. 271 (Cell Physiol. 40): C1424-C1437, 1996.
4. Binko, J., and H. Majewski. 17β-Estradiol reduces vasoconstriction in endothelium-denuded rat aortas through inducible NOS. Am. J. Physiol. 274 (Heart Circ. Physiol. 43): H853-H859, 1998.
5. Boyle, E. M., S. T. Lille, E. Allaire, A. W. Clowes, and E. D. Verrier. Endothelial cell injury in cardiovascular surgery-atherosclerosis. Ann. Thorac. Surg. 63: 885-894, 1997.
6. Bruckdorfer, K. R. Antioxidants, lipoprotein oxidation, and arterial function. Lipids 31, Suppl.: S83-S85, 1996.
7. Cooke, J. P., and V. J. Dzau. Nitric oxide synthase: role in the genesis of vascular disease. Annu. Rev. Med. 48: 489-509, 1997.
8. Dinarello, C. A. An update on human interleukin-1: from molecular biology to clinical relevance. J. Clin. Immunol. 5: 287-297, 1985.
9. Dudley, D. T., L. Pang, S. J. Decker, A. J. Bridges, and A. R. Saltiel. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA 92: 7686-7689, 1995.
10. Eason, S., and W. Martin. Involvement of tyrosine kinase and protein kinase C in the induction of nitric oxide synthase by lipopolysaccharide and interferon-gamma in J774 macrophages. Arch. Int. Pharmacodyn. Ther. 330: 225-240, 1995.
11. Farb, A., S. J. Lee, D. H. Min, Z. Parandoosh, J. Cooks, J. McDonald, G. F. Pierce, and R. Virmani. Vascular smooth muscle cell cytotoxicity and sustained inhibition of neointimal formation by fibroblast growth factor 2-saprin fusion protein. Circ. Res. 80: 842-550, 1997.
12. Feng, L., W. Sun, Y. Xia, W. W. Tang, P. Chanmugam, E. Soyoola, C. B. Wilson, and D. Hwang. Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression. Arch. Biochem. Biophys. 307: 361-368, 1993.
13. Förstermann, U., and H. Kleinert. Nitric oxide synthase: expression and expressional control of the three isoforms. Naunyn Schmiedeberg's Arch. Pharmacol. 352: 351-364, 1995.
14. Gavrielli, Y., Y. Sherman, and S. A. Ben-Sasson. Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J. Cell Biol. 119: 493-501, 1992.
15. Gazit, A., N. Osherov, I. Posner, P. Yaish, E. Poradosu, C. Gilon, and A. Levitzki. Tyrphostins. 2. Hetrocyclic and alpha-substituted benzylidenemalononitrile tyrphostins as potent inhibitors of EGF receptor and ErbB2/neu tyrosine kinase. J. Med. Chem. 34: 1896-1907, 1991.
16. Griscavage, J. M., S. Wilk, and L. J. Ignarro. Serine and cysteine proteinase inhibitors prevent nitric oxide production by activated macrophages by interfering with transcription of the inducible NO synthase gene. Biochem. Biophys. Res. Commun. 215: 721-729, 1995.
17. Griscavage, J. M., S. Wilk, and L. J. Ignarro. Inhibitors of the proteasome pathway interfere with induction of nitric oxide synthase in macrophages by blocking activation of transcription factor NF-kappa B. Proc. Natl. Aci. Sci. USA 93: 3308-3312, 1996.
18. Hansson, G. K., Y. J. Geng, J. Holm, P. Hardhammar, A. Wennmalm, and E. Jennische. Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury. J. Exp. Med. 180: 733-738, 1994.
19. Hayry, P., E. Aavik, and M. Myllarniemi. Blockade of growth factor synthesis and growth factor action: two possible sites of interference in allograft vessel disease and coronary bypass or balloon injury. Metabolism 45: 101-103, 1996.
20. Hecker, M., C. Preiss, and V. B. Schini-Kerth. Induction by staurosporine of nitric oxide synthase expression in vascular smooth muscle cells: role of NF-kappa B, CREB and C/EBP beta. Br. J. Pharmacol. 120: 1067-1074, 1997.
21. Herbert, J. M., J. M. Augereau, J. Gleye, and J. P. Maffrand, Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 172: 993-999, 1990.
22. Jabbar, S. A., A. V. Hoffbrand, and R. G. Wickremasinghe. Defects in signal transduction pathways in chronic B lymphocytic leukemia cells. Leuk. Lymphoma 18: 163-170, 1995.
23. Joly, G. A., M. Ayres, and R. G. Kilbourn. Potent inhibition of inducible nitric oxide synthase by geldanamycin, a tyrosine kinase inhibitor, in endothelial, smooth muscle cells and in rat aorta. FEBS Lett. 403: 40-44, 1997.
24. Joly, G. A., V. B. Schini, and P. M. Vanhoutte. Balloon injury induces nitric oxide synthase in rat carotid arteries. J. Card. Pharmacol. 20, Suppl.: S151-S154, 1992.
25. Knowles, R. G., and S. Moncada. Nitric oxide synthase in mammals. Biochem. J. 298: 249-259, 1994.
26. Landezberg, B. R., W. H. Frishman, and K. Lerrick. Pathophysiology and pharmacological approaches for prevention of coronary artery restenosis following coronary artery balloon angioplasty and related procedures. Prog. Cardiovasc. Dis. 39: 361-398, 1997.
27. Li, P. F., R. Dietz, and R. von Harsdorf. Differential effect of hydrogen peroxide and superoxide anion on apoptosis and proliferation of vascular smooth muscle cells. Circulation 96: 3602-3609, 1997.
28. Lyons, C. R. The role of nitric oxide in inflammation. Adv. Immunol. 60: 323-371, 1995.
29. McBride, W., R. A. Lange, and L. D. Hillis. Restenosis after successful angioplasty. Pathophysiology and prevention. New. Engl. J. Med. 318: 1734-1737, 1988.
30. McKendrick, J. D., K. Paisley, S. Eason, K. B. Mian, and W. Martin. Induction of nitric oxide synthase by endotoxin in rat isolated aorta but not in rat aortic smooth muscle cells grown in culture from explant. Arch. Int. Pharmacodyn. Ther. 330: 206-224, 1995.
31. McKenna, T. M. Prolonged exposure of rat aorta to low levels of endotoxin in vitro results in impaired contractility. Association with vascular cytokine release. J. Clin Invest. 86: 160-168, 1990.
32. Moritoki, H., S. Takeuchi, W. Kondoh, T. Hisayama, A. M. Hashizume, and K. Noda. Role of endotoxin in L-arginine-induced relaxation of rat thoracic aorta mediated by muscle-derived nitric oxide. Arch. Int. Pharmacodyn. Ther. 327: 152-165, 1994.
33. Mulligan, M. S., S. Moncada, and P. A. Ward. Protective effects of inhibitors of nitric oxide synthase in immune complex-induced vasculitis. Br. J. Pharmacol. 107: 1159-1162, 1992.
34. Munzel, T., T. Heitzer, and D. G. Harrison. The physiology and pathophysiology of the nitric oxide/superoxide system. Herz 22: 158-172, 1997.
35. Owens, G. K. Regulation of differentiation of vascular smooth muscle cells. Physiol. Rev. 75: 487-517, 1995.
36. Perhnan, H., L. Maillard, K. Krasinski, and K. Walsh. Evidence for rapid onset of apoptosis in medial smooth muscle cells after balloon angioplasty. Circulation 95: 782-786, 1997.
37. Post, M. J., B. J. de Smet, Y. van der Helm, C. Borst, and R. E. Kuntz. Arterial remodelling after balloon angioplasty or stenting in an atherosclerosis experimental model. Circulation 96: 996-1003, 1997.
38. Radomski, M. W., and E. Salas. Nitric oxide-biological mediators, modulators and factor of injury: its role in the pathogenesis of atherosclerosis. Atherosclerosis 118, Suppl.: S69-S80, 1995.
39. Rimarachin, J. A., J. A. Jacobson, P. Szabo, J. Maclouf, C. Creminon, and B. B. Weksler. Regulation of cyclooxygenase-2 expression in aortic smooth muscle cells. Arterioscler. Thromb. 14: 1021-1031, 1994.
40. Seccombe, J. F., and H. V. Schaff. Coronary artery endothelial function after myocardial ischaemia and reperfusion. Ann. Thorac. Surg. 60: 778-788, 1995.
41. Sherman, M. P., E. E. Aeberhard, V. Z. Wong, J. M. Griscavage, and L. J. Ignarro. Pyrrolidine dithiocarbamate inhibits induction of nitric oxide synthase activity in rat alveolar macrophages. Biochem. Biophys. Res. Commun. 191: 1301-1308, 1993.
42. Singh, K., J. L. Balligand, T. A. Fischer, T. W. Smith, and R. A. Kelly. Regulation of nitric oxide synthase in cardiac myocytes and microvascular endothelial cells. Role of extracellular signal-regulated kinase 1 and 2 (ERK1/ERK2) and STAT1 alpha. J. Biol. Chem. 271:1111-1117, 1996.
43. Szabo, C. The pathophysiological role of peroxynitrite in shock, inflammation, and in ischemia-reperfusion injury. Shock 6: 79-88, 1996.
44. Szabo, C., B. Zingarelli, and A. L. Salzman. Role of poly-ADP ribosyltransferase activation in the vascular contractile and energetic failure elicited by exogenous and endogenous nitric oxide and peroxynitrite. Circ. Res. 78: 1051-1063, 1996.
45. Thyberg, J. Differentiated properties and proliferation of arterial smooth muscle cells in culture. Int. Rev. Cytol. 169: 183-265, 1996.
46. Tzeng, E., Y. M. Kim, B. R. Pitt, A. Lizonova, I. Kovesdi, and T. R. Billiar. Adenoviral transfer of the inducible nitric oxide synthase gene blocks endothelial cell apoptosis. Surgery 122: 255-263, 1997.
47. Verrier, E. D., and E. M. Boyle. Endothelial cell injury in cardiovascular surgery. Ann. Thorac. Surg. 62: 915-922, 1996.
48. Vodovotz, Y., and C. Bogdon. Control of nitric oxide synthase expression by transforming growth factor-beta: implications for homeostasis. Prog. Growth Factor Res. 5: 341-351, 1994.
49. Wan, Y., T. Kurosaki, and X. Y. Huang. Tyrosine kinase in activation of the MAP kinase cascade by G-protein-coupled receptors. Nature 380: 541-544, 1996.
50. White, C. R., J. Shelton, S. J. Chen, V. Darleyusmar, L. Allen, C. Nabors, P. W. Sanders, Y. F. Chen, and S. Oparil. Estrogen restores endothelial cell function in an experimental model of vascular injury. Circulation 96: 1624-1630, 1997.
51. Yan, Z. Q., T. Yokota, W. Zhang, and G. K. Hansson. Expression of inducible nitric oxide synthase inhibits platelet adhesion and restores blood flow in the injured artery. Circ. Res. 79: 38-44, 1996.
52. Yokoi, H., H. Daida, Y. Kuwabara, H. Nishikawa, E. Takatsu, H. Tomihara, Y. Nakata, Y. Kutsumi, S. Ohshima, S. Nishiyama, A. Seki, K. Kato, S. Nishimura, T. Kanoh, and H. Yamaguchi. Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the Probucol Angioplasty Restenosis Trial. J. Am. Coll. Cardiol. 30: 855-862, 1997.
53. Ziehe, M., L. Morbidelli, E. Masini, S. Amerini, H. J. Granger, C. A. Maggi, P. Geppetti, and F. Ledda. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J. Clin. Invest. 94: 2036-2044, 1994.